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Background: A large-scale study was set up in order to study the epidemiology, clinical aspects, and immunopa-
thology of gestational and placental malaria in north-west Colombia. In this region, recent reports using a qPCR
technique, confirmed frequencies of infection, by Plasmodium falciparum or Plasmodium vivax, up to 45%. Given the
high rates of infection observed both in mother and placenta, a first exploratory study was proposed in order to
characterize the effect on the inflammation status, tissue damage and hypoxia in Plasmodium spp. infected
placentas.
Methods: A descriptive, prospective, cross-sectional design was applied to pregnant women with (PM+) and
without (PM-) placental malaria. Messenger RNA expression of Fas, FasL; COX-1, COX-2, HIF, VEGF, and the cytokines
IL-2, IL-4, IL-10, IFN-γ and TNF, were measured in peripheral and placental blood using a quantitative PCR. The
percentage of apoptotic cells was determined with a TUNEL assay.
Results: In total 50 placentas were studied: 25 were positive for submicroscopic infection and 25 were negative for
Plasmodium infection. Expression of IL-4 and IL-10 was observed high in placental tissue of PM+, while IL-2 was
high in peripheral blood of the same group. Expression of TNF and IFNγ in peripheral blood of the PM + group was
high. Similarly, the apoptotic index and Fas expression were significantly high in PM+. However, FasL expression
was observed low in PM + compared to PM-. Inflammation markers (HIF, VEGF) and hypoxia markers (COX-1, COX-2)
were high in the PM + group.
Conclusion: During placental malaria expression of some pro-inflammatory cytokines is up-regulated and markers
of hypoxia and tissue damage are increased in cases of submicroscopic infection.
Keywords: Submicroscopic, Placental malaria, Plasmodium, Cytokine, Inflammation, HypoxiaBackground
Globally, an estimated 125 million pregnancies are at
risk of malaria each year [1] and the disease causes sub-
stantial maternal and infant morbidity/mortality [2]. Both
Plasmodium falciparum and Plasmodium vivax can cause
adverse pregnancy outcomes, including maternal anaemia
and low birth weight, albeit different mechanisms appear* Correspondence: aemaestre@gmail.com
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In the case of P. falciparum, adherence of infected
erythrocytes to chondroitin sulfate A (CSA), present on
the trophoblast surface, is crucial in the pathophysiology
of the disease [4], since parasite sequestration results in
inflammatory responses that can be harmful to both the
mother and the foetus [5].
Women inhabiting areas with different degrees of en-
demicity experience variable exposure to infection and
this affects the course of disease [6]. In areas of high
stable transmission, as in most sub-Saharan regions,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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nancy, and placental malaria is often asymptomatic,
but associated with severe maternal anaemia and foetal
growth retardation. In these regions, placental malaria
is most frequent and severe in first time mothers, and
women develop specific immunity against placental
forms of infected erythrocytes over successive preg-
nancies. On the other hand, in areas of low unstable
transmission, malaria is symptomatic in women of all
parities and is associated with high rates of foetal loss
and maternal death [7]. In such regions, increased suscep-
tibility of primigravidae, compared to multigravidae, has
been rarely documented [8].
Recent extensive reviews have focused on the patho-
genesis and immunity of gestational and placental mal-
aria caused by P. falciparum, specifically the molecular
aspects of these infections, the associated damage to
the placenta, and the consequences on the mother, the
placenta and the foetus [3]. A significant role for increased
cytokines (TNF, IFN-γ and IL-10) and apoptosis in tropho-
blast damage, low birth weight and preterm delivery during
placental malaria, has been observed [3]. Some studies con-
cluded that complications during pregnancy and foetal
death observed in P. falciparum placental malaria might
be determined by changes in the regulation of apoptosis,
via Fas /FasL [9], and increased Th1 immune responses in
the syncytiotrophoblast [10,11]. In addition, few reports
identified a relationship between hypoxia and placental
malaria [12,13], although an association between hypoxia
and intrauterine growth retardation was observed in pre-
eclampsia [14]. As for P. vivax infection during pregnancy,
these phenomena remain to be studied.
On a routine basis, detection of parasites in placenta
requires examination of histological sections of fixed pla-
cental tissue or microscopy of placental blood [15]. How-
ever, application of highly sensitive molecular techniques
confirmed that the frequency of low level (submicroscopic)
infections is higher than expected in all endemic regions
[16,17]. Sensitive molecular methods typically diagnose ap-
proximately twice as many infections as microscopy. Differ-
ent authors have suggested that even such low parasitaemia
infections can result in pregnancy complications such as
maternal anaemia and low birth weight [18]. However,
the epidemiological characteristics and the consequences
associated with submicroscopic plasmodial infection in
pregnant women have been poorly evaluated [19,20].
Most knowledge gathered about pregnancy-associated
malaria resulted from studies in areas of Africa where
P. falciparum is highly endemic. In Colombia, where
P. vivax represents 60-70% of the total reported cases,
malaria in pregnancy constitutes a public health problem
[15,21] with a high frequency of submicroscopic infections
[16,15]. During the past 5 years, several reports contrib-
uted to the definition and understanding of the problemof gestational malaria in north-west Colombia [15,16,22].
To further recognize the effect of malaria infection on
the pathophysiology of placental damage and to define
the significance of low level infections in this context,
a study was conducted to explore apoptosis, inflammation,
and hypoxia in placental tissue, and to measure cytokines
in maternal and placental blood, in relation to the pres-
ence of submicroscopic placental infection.
Methods
Study site
Women were recruited from January 2007 to April 2011,
at the hospital obstetric facilities in the municipalities
of Monteria (08°45′N, 75°53′W), and Puerto Libertador
(07°53′35′ N, 75°40″16″ W) of the Uraba-Sinu-San Jorge-
Bajo Cauca region of Colombia. This region has an esti-
mated area of 43,506 km2, a population of 2.5 million at
risk of malaria, with a mean annual parasite index of 35.8
cases/1,000 inhabitants [23]. The region has a low and
stable malaria transmission intensity, with no marked fluc-
tuations in the number of malaria cases during the year.
The recorded prevalence of gestational malaria in the re-
gion was 9.1% by thick smear and 14.0% by PCR, while
placental malaria was observed in 3.3% and 16.5%, re-
spectively [24].
Study design and sample selection
The study was part of a larger project aimed at exploring
the epidemiology, clinical aspects and immunopathology of
gestational and placental malaria in north-west Colombia,
from which partial results have been reported elsewhere
[21,24]. A total 2,000 pregnant women were recruited in
a sequential fashion for the main study. Clinical and epi-
demiological surveys were applied to all those women.
Based on the availability and quality of material collected
from peripheral blood and placental tissue, a subset of
subjects was selected from the records of the 2,000
women recruited in the main project, to explore the effect
of malaria infection on the pathophysiology of placental
damage. Regardless of the time of the year or the year of
collection, a total 50 subjects, non-matched, were studied:
25 with confirmed placental infection and 25 without
Plasmodium spp. infection. The status of infection was
defined by thick smear and real-time PCR (qPCR) of
placental blood. Positive infected units were those with a
negative diagnosis by microscopy and a positive qPCR re-
sult; negative units were negative by both tests.
Inclusion and exclusion criteria
Inclusion criteria were voluntary acceptance to participate
in the study, signature of the informed consent, permanent
residency (>1 year) in the malaria endemic region, negative
history of pre-eclampsia and negative HIV and TORCH
tests. The exclusion criterion was withdrawal of consent.
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After enrolment, a questionnaire was completed which
recorded data including age, number of pregnancies,
number of malaria episodes during the ongoing pregnancy
(based on antenatal records) and antimalarial treatment
administered. In addition, labour/delivery and infant out-
comes data, as well as maternal haemoglobin value, were
obtained from the delivery chart. Placentas were processed
immediately after delivery and maternal peripheral blood
was obtained within 24 hours. After cleaning with saline,
two ~1 cm3 sections of placenta were removed from the
maternal side of the organ and blood was collected by
aspiration into a tube containing EDTA. From mothers,
3 ml of peripheral blood was obtained and collected
into EDTA containing vials. Thick smears were pre-
pared from placental and mother’s blood and blood
spots (approximately 100 μl of blood) were placed onto
Whatman 3 mm filter paper for molecular diagnosis.
One tissue fragment was preserved in RNA later® before
processing for expression of markers of apoptosis, hypoxia
and inflammation, and the remaining tissue fragment was
fixed with 10% buffered formalin (pH 7.0-7.4), before em-
bedding in paraffin, for the TUNEL assay.
Diagnosis of infection by Plasmodium
Plasmodium infection was evaluated in mother’s peripheral
and placental blood by microscopy of Field-stained thick
films and qPCR. An experienced microscopist based at
the field laboratory determined the presence of infection
by counting the number of parasites per 200 leukocytes,
based on a mean count of 8,000 leukocytes per microliter
of blood. Samples were negative when no parasites were
detected in 200 high power (100x) fields. For the qPCR,
DNA was extracted from a 6 mm2 fragment of placenta
using the Chelex method described by Plowe et al.
[25]. A qPCR was performed as described previously
[26]. Briefly, samples were first tested for Plasmodium
using a genus-specific set of primers and probe. The
reaction was performed in a final volume of 25 μl con-
taining 5 μl of DNA, 12.5 μl of TaqMan universal mas-
ter mix (Applied Biosystems), 200 nM of each primer
(Plasmo1 and Plasmo2), 50 nM of Plasprobe on the ABI
7500 FAST platform, under universal cycling conditions
as published. Samples with a cycle threshold (Ct) value
under 45 were tested in a duplex species-specific real-time
PCR reaction for P. falciparum and P. vivax [26].
Expression analysis of cytokines and markers of tissue
damage and inflammation
Cytokines were measured in mRNA isolated from maternal
whole blood and placental tissue, while markers of tis-
sue damage, hypoxia and inflammation were measured
in mRNA isolated from placental tissue. Relative quan-
titation for expression analysis was performed using areverse-transcription real time PCR assay (RT-PCR).
Total RNA was extracted using QIAamp RNA Blood Mini®
(QIAGEN) and cDNA was synthesized using First Strand
cDNA Synthesis® (Fermentas). The reaction was set up
in a Roche LightCycler® or ABI 7500. Table 1 details the
primers and probes used. The following genes were ana-
lysed for expression: Fas, FasL; COX-1, COX-2, HIF, VEGF,
and the cytokines IL- 2, IL-4, IL-10, IFN-γ and TNF. The
efficiency of the PCR reactions was determined based on
mRNA extracted from a stimulated BeWo cell culture or
peripheral mononuclear cells from a donor. Complemen-
tary DNA was serially diluted and expression of β-actin was
used to normalize the assays using the delta delta CT
method (ΔΔCt) as described previously [27].
Quantification of apoptosis
Apoptosis in placentas was assessed by a TUNEL assay as
described earlier [28]. Placental sections were deparaf-
finized and placed on Fisherbrand Superfrost Plus® slides.
Detection of cells undergoing apoptosis was performed
using the kit DeadEnd Colorimetric System® Promega
TUNEL, according to the manufacturer’s protocol. The
apoptotic index was calculated based on the proportion
of TUNEL stained cells observed in 10 fields (40x). The
test was performed in a blinded fashion, for this samples
were assigned a code which was revealed once all results
were available.
Statistical analyses
Data were analysed using Excel and SPSS 19. Significance
was set at p < 0.05. Non-parametric tests were used for
data analysis and the U Mann–Whitney test and the
Kruskal-Wallis test were used for correlations. Accord-
ing to the data distribution, the variable number of
DNA copies/μl of template was grouped by convenience
as follows: Group 1 (0 copies-no infection); Group 2
(0.01 to 1.99 copies/μl), Group 3 (2.00 to 100 copies/μl),
and Group 4 (> 100 copies/μl) [16].
Ethical considerations
Pregnant women or guardians (in case of <18 years of age)
signed a voluntary consent form. The study involved a
minor risk and approval was granted by the Comite de
Etica of Instituto de Investigaciones Medicas, Facultad de
Medicina, Universidad de Antioquia (Approval Certificate
number IIM 889ADV).
Results
All fifty placentas were negative for Plasmodium spp. by
microscopy, and 25 of them were positive for infection
by qPCR: 16 P. falciparum, six P. vivax and three mixed
infection. The characteristics of the women from which
placentas were collected are summarized in Table 2. In
general, women were in their first or second pregnancy,
Table 1 Primers and probes used in this study
Marker and cytokine gene Sequence (5′-3′) Product Size (pb) ID
B-actin F: CGAGCGCGGCTACAGCTT 58 pb NM_001101
R: CCTTAATGTCACGCACGATT
P: ACCACCACGGCCGAGCGG
FasL F: CTGGGGATGTTTCAGCTCTTC 231 NM_152872
R: GTCCTGCTTTCTGGAGTGAAG
Fas F: AAGGAGTACACAGACAAAGCCC 170 NM_000043.3
R: GGGTGGCTTTGTCTTCTTCTT
COX1 F:AGCAGCTTTTCCAGACGACC 157 pb NM_000962
R:CGGTTGCGGTATTGGAACTG
P: CTGGCCTCAGCACTCTGGAATGACAA
COX2 F: CCTGATCCCCAGGGCTCAAAC 79 pb NM_000963
R: TTGGTGAAAGCTGGCCCTCG
P: TGCCCAGCACTTCACGCATCAGTT
VEGF F: TCTACCTCCACCATGCCAAGT 102 pb AB021221
R: TGCGCTGATAGACATCCATGA
P: CCAGGCTGCACCCATGGCAGA
HIF F: CCAAATCCAGAGTCACTGGAACTT 96 pb NM_001530
R: AGGTGAACTTTGTCTAGTGCTTCCAT
P: TACCATGCCCCAGATTCAGGATCAGACAC
IL-2 F: TGATTTTGAATGGAATTAATAATTACAAG 95 pb NM_000586.3
R: TTTCAGTTCTGTGGCCTTCTT
P: CCCAAACTCACCAGGATGCTCACATT
IL-4 F: GCCTCACAGAGCAGAAGACTC 75 pb NM_172348.1
R: CAGTTGTGTTCTTGGAGGCA
P: TGCACCGAGTTGACCGTAACAGACA
IL-10 F: CCTGGAGGAGGTGATGCCCCA 131 pb NM_000572.2
R: CAGCGCCGTAGCCTCAGCC
P: CAAGGCGCATGTGAACTCCCTG
IFNγ F: GAAGAATTGGAAAGAGGAGAGTGA 218 pb NM_029419.12
R: TGGACATTCAAGTCAGTTACCG
P: TTCCTTGATGGTCTCCACACTCTTTTGG
TNF F. GCCCAGGCAGTCAGATCA 74 pb NM_000594.2
R: GCTTGAGGGTTTGCTACAACA
P: CCCGAGTGACAAGCCTGTAGCCC
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(≥38 weeks), haemoglobin levels were similar in the two
groups and the mean birth weight was similar and within
normal range (<2,500 grams) in all. Interestingly, 19/25 per-
ipheral blood samples from mothers with positive placentas
were also positive, either by microscopy or qPCR by the
same Plasmodium species infecting the placenta.
Cytokine expression in pregnant women and placentas
Maternal peripheral blood and placental tissue were
evaluated for the expression (mRNA) of IFN-γ, TNF, IL-2,IL-4 and IL-10. In both compartments, expression of IFN-γ,
TNF, and IL-10 was significantly higher in PM+when com-
pared to PM-. Meanwhile, expression of IL-4 was high in
placentas in PM+, and IL-2 was high in peripheral blood
of the same group (Table 3). In peripheral blood of the
PM + group, the cytokines TNF and IFN-γ were ele-
vated and positively correlated (rho = 0.749, P = 0.000
with n = 50). In addition, for IL-4 and IL-10 a lower
(rho = 0.431, P = 0.002 with n = 50), but nevertheless
significant, correlation was observed in placenta, but not
in peripheral blood (rho = 0.048, P = 0.740 with n = 50).
Table 2 General characteristics of parturient women participating in the study, according to placental infection status
by qPCR
Characteristic Placental malaria by qPCR
No (N = 25) Yes (N = 25)
Age of mother (years) 22.6 (15–32) 22.43 (range 14–36)
Number of gestations 1.84 (range 0–6) 1.91 (range 0–6)
Weeks of pregnancy 37.6 (range 32–41) 38.3 (range 27–41)
Mother’s haemoglobin (g/dL) at delivery 11.38 (range 7.15–18.30) 10.83 (range 9.00–13.30)
Identification of infecting species in mother’s peripheral blood - 19* (11 P. falciparum, 7 P. vivax, 1 mixed)
Birth weight (grams) 2,891 (range 1,780–3,900) 3,305 (range 2,600–4,400)
*6 subjects were negative for infection in peripheral blood.
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(rho = 0.676, p = 0.000 n = 50), IL-2 and IFN-γ (rho = 0.760,
p = 0.000 n = 50), all in peripheral blood. In this same com-
partment, IL-4 did not correlate (p ≤ 0.406), but IL-10 posi-
tively correlated with IL-2, TNF and IFN-γ (p = 0.000).
In general, the differences observed in expression of
cytokines in peripheral blood and placenta between PM+
and PM-, persisted when analysis was performed taking
into account the infecting species (Table 4).
Apoptosis, inflammation and hypoxia markers in
placental malaria
According to TUNEL assay, the mean apoptotic index
observed in the group PM+was 62.37% (range 55-79%)
(Table 5), and this was significantly higher when com-
pared with the PM- group (44.88%). Similarly, mean Fas
expression was significantly higher in PM + than in PM-
(6.52 vs. 3.42). However, FasL expression was higher in
PM- than in PM + (6.95 vs. 5.60, p < 0.05) (Table 5).
The inflammation markers HIF and VEGF were observed
high in the PM+ group, but only VEGF was significantly
different. As for the hypoxia markers, COX-1 and COX-2,Table 3 Cytokine expression (Mean ratio ± standard
deviation) in placental tissue and maternal peripheral
blood according to the infection status
Placental tissue Infected Uninfected P (U Mann–Whitney)
IL-2 1.00 ± 0.42 0.96 ± 0.30 >0.05
IFN-γ 9.00 ± 0.811 0.46 ± 0.37 0.0001
TNF 6.16 ± 0.75 0.83 ± 0.45 0.0001
IL-4 1.60 ± 0.40 1.05 ± 0.62 0.0001
IL-10 3.50 ± 0.93 0.18 ± 0.18 0.0001
Maternal
peripheral blood
IL-2 3.65 ± 1.11 1.18 ± 0.50 0.0001
IFN-γ 6.53 ± 2.38 1.10 ± 0.72 0.0001
TNF 1.53 ± 0.41 0.76 ± 0.46 0.0001
IL-4 1.63 ± 0.34 1.41 ± 0.50 >0.05
IL-10 2.45 ± 0.64 0.65 ± 0.50 0.0001both were significantly high in the PM+ group. In general,
all evaluated markers of tissue damage were up regulated in
the placentas of the PM+ group (Table 5).
Analysis of apoptosis, inflammation and hypoxia markers
according to the Plasmodium species observed in placenta,
confirmed similar results to those observed between the
PM+ group and non-infected placentas (Table 6).
Relationship between markers of apoptosis/inflammation/
hypoxia and cytokine expression in placenta
No significant correlation was observed between IL-2
and any of the apoptosis/inflammation/hypoxia markers.
Similarly, VEGF failed to correlate with the expression of
any cytokine. On the other hand, the percentage of
apoptotic cells and the expression of Fas, COX1, COX2
and HIF positively correlated with IFN-γ, TNF, IL-4 and
IL-10. Meanwhile, FasL negatively correlated with the
remaining variables (Table 7).
Relatioship between biomarkers of apoptosis/inflammation/
hypoxia and placental parasite density in placenta
Placental parasite density was calculated using a qPCR
assay as detailed in the methods section. In order to fa-
cilitate analysis, and based on the frequency distribu-
tion of data, results were categorized according to the
copies of parasite DNA measured per PCR μl of total
purified DNA: Group 1 (0 copies-no infection); Group 2
(0.01 to 1.99 copies/μl), Group 3 (2.00 to 100 copies/μl),
and Group 4 (> 100 copies/μl) [16]. In general, signifi-
cant differences were observed between Group 1 and
the remaining groups as a whole. Copy number correlated
positively and significantly with the percentage of apoptotic
cells, and expression of Fas, COX1, COX2, HIF, IFN-γ,
TNF, IL-4 and IL-10 (p = 0.000 and for IL4 p = 0.017).
However, no significant correlation (p ≥ 0.078) was ob-
served between expression of FasL, VEGF and IL-2 in
relation to the copies of parasite DNA.
Discussion
Although the effects of malaria infection on the mother
and the foetus depend upon multiple factors, the host
Table 4 Cytokine mean (standard deviation) expression ratio in placenta and maternal peripheral blood according to
plasmodial species
Cytokine Placental tissue Maternal peripheral blood
Groupa Mean (S.D.) P* Mean (S.D.) P*
IL2 PM- 0.95 (0.28) 1.18 (0.50)
PM + Pf 1.08 (0.43) 3.51 (1.20)
PM + Pv 0.95 (0.42) 3.92 (1.12)
PM +mixed 0.67 (0.29) 0.332 3.78 (0.70) 0.000
IFNγ PM- 0.46 (0.37) 1.08 (0.72)
PM + Pf 9.00 (0.92) 6.06 (2.83)
PM + Pv 8.59 (0.57) 7.60 (0.78)
PM +mixed 9.33 (0.31) 0.000 6.85 (0.74) 0.000
TNF PM- 0.83 (0.45) 0.76 (0.46)
PM + Pf 6.23 (0.91) 1.47 (0.43)
PM + Pv 6.05 (0.41) 1.48 (0.21)
PM +mixed 6.00 (0.00) 0.000 1.93 (0.46) 0.000
IL4 PM- 1.05 (0.62) 1.41 (0.50)
PM + Pf 1.56 (0.43) 1.64 (0.30)
PM + Pv 1.48 (0.21) 1.63 (0.49)
PM +mixed 1.96 (0.41) 0.024 1.52 (0.28) 0.634
IL10 PM- 0.18 (0.18) 0.65 (0.50)
PM + Pf 3.33 (1.04) 2.23 (0.54)
PM + Pv 3.57 (0.69) 2.93 (0.69)
PM +mixed 4.08 (0.61) 0.000 2.68 (0.58) 0.000
aPM- without placental malaria (n = 25); PM + Pf with placental infection by P. falciparum (n = 16); PM + Pv with placental infection by P. vivax (n = 6); PM +mixed
with placental by both species (n = 3).
*(Kruskal-Wallis).
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are specifically associated with complications observed
before birth and around the neonatal period [3]. This
study evaluated the important immunological aspects and
molecular mechanisms associated with tissue damage in
the placenta, which contribute to the understanding of theTable 5 Ratio of expression and proportion of apoptotic
cells in placental tissue in infected and uninfected placentas




Apoptotic cells 62.37% ± 10.02% 44.88% ± 2.15 0.0001
Fas 6.53 ± 2.49 3.42 ± 0.84 0.0001
FasL 5.60 ± 2.13 6.95 ± 1,16 0.003
Hypoxia
HIF 0.96 ± 1.15 0.21 ± 0.22 0.0001
VEGF 0,14 ± 0.14 0.12 ± 0.15 >0.05
Inflammation
COX-1 6.95 ± 3.14 0.73 ± 0.41 0.0001
COX-2 2.86 ± 0.99 0.42 ± 0.29 0.0001pathophysiology of placental infection. Complex cellular
and molecular mechanisms, such as apoptosis, hypoxia
and inflammation have not been evaluated in cases of
placental infection by Plasmodium spp in this endemic
region. Such mechanisms are important to a healthy
pregnancy since they contribute to implantation and
promote placental development [16].
This is a first exploratory study on the subject in
women from a region where both P. falciparum and
P. vivax are endemic and is the first study to report
on apoptosis and tissue injury during submicroscopic
placental infection. All studied groups came from the
same malaria endemic region as to control for any socio-
epidemiology associated bias. According to a recent report
[16], most placental infections at delivery in this region
were sub-clinical and thick smear microscopy examin-
ation failed to diagnose them. Based on these findings,
the current study included subjects in which diagnosis
of infection was confirmed by qPCR.
Changes in apoptosis have been scarcely studied in
placental malaria. In other pathologies such as pre-
eclampsia, the high rate of apoptosis has been directly
linked with intrauterine growth restriction [29]. Importantly,
Table 6 Mean value (standard deviation) of Apoptosis index and ratio (standard deviation) of expression of
inflammation and hypoxia markers according to plasmodial species infecting the placenta
PM-a PM + Pf a PM + Pv a PM +mixed P*
Apoptotic cells index 44.78 (2.15) 71.32 (4.45) 61.04 (5.96) 57.56 (3.06) 0.000
Fas 3.2 (0.84) 5.18 (2.11) 6.57 (1.61) 10.49 (2.09) 0.000
FasL 6.74 (1.16) 4.49 (2.47) 5.5 (2.82) 5.68 (2.3) 0.009
HIF 0.1 (0.22) 0.37 (0.66) 0.35 (0.47) 0.82 (2.97) 0.000
VEGF 0.05 (0.15) 0.09 (0.17) 0.06 (0.07) 0.09 (0.06) 0.412
COX1 0.43 (0.41) 6.64 (3.54) 5.22 (0.69) 5.9 (3.4) 0.000
COX2 0.24 (0.29) 2.45 (0.93) 2.71 (0.82) 2.19 (1.82) 0.000
aPM- without placental malaria (n = 25); PM + Pf with placental infection by P. falciparum (n = 16); PM + Pv with placental infection by P. vivax (n = 6); PM +mixed
with placental infection by both species (n = 3).
*(Kruskal-Wallis).
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was higher than in PM-. Early reports on apoptosis in mal-
aria infected placentas showed no difference in the propor-
tion of apoptotic cells when compared to uninfected ones
[30]. A possible explanation for the dissimilar results from
those reported here might be the application of different
techniques- TUNEL vs. haematoxylin-eosin staining.
Fas and FasL expression have been proposed as markers
of apoptosis, and this is considered an important mech-
anism by which cytokines act locally and may influence
critical signaling processes. In in vitro studies with cell
models and placental tissue explants stimulated with
pro-inflammatory cytokines, the expression of Fas and
FasL was high and similar to the results reported here [31].
Taken together, these observations implicate apoptosis as a
host response or a downstream effect of malaria infection
in the placenta.
In the current study, increased apoptosis in infected
placentas was also associated with high expression of
the pro-inflammatory cytokines IFN-γ and TNF. Similar
observations with increased expression of Th1 cytokines
such as IL-2, TNF, IFN-γ and decreased Th2 cytokines
such as IL-6 and TGF-β have been reported by others
[31], and haemozoin deposition and haemozoin-loaded
macrophages have implicated in the induction of in-
flammation in the throphoblast [30,32]. Ongoing stud-
ies are exploring the association between haemozoinTable 7 Correlation (rho, p) between the expression of cytoki
and inflammation in placental tissue, regardless of the infect
INFγ T
Apoptotic cells (%) 0.709 (0.000) 0.708
Fas 0.673 (0.000) 0.646
FasL −0.385 (0.006) −0.28
COX1 0.794 (0.000) 0.857
COX2 0.784 (0.000) 0.826
HIF 0.701 (0.000) 0.570deposits and the cytokine profile in infected placentas
in Colombia.
Other authors, based on high levels detected in serum
of women with gestational malaria, have proposed IL-10
as biomarker of placental infection [33] and a definitive
marker of inflammation during placental malaria [34].
This hypothesis is supported in the current study by the
higher expression of IL-10 observed in the infected vs.
uninfected placentas. The increased expression of this
cytokine in cases of submicroscopic infection is a novel
and promising finding.
Hypoxia has been associated with complications from
placental malaria infection [35]. However, few studies
have explored the relationship between malaria and
placental hypoxia [36]. Common histological changes
associated with infection such as basal membrane
thickening, mononuclear infiltrates and presence of
parasites in the intervillous space, affect oxygen trans-
port across the placenta. Some hypoxia mechanisms
include oxygen consumption by infiltrating cells, de-
creased blood perfusion and reduction of the effective
foetal-maternal surface area [36]. In consequence, a
physiological adaptation to hypoxia results in syncytial
knot formation, an alteration often reported during
placental infection by Plasmodium [8]. Similar to the
current report, Boeuf and colleagues in 2008, observed
increased expression of HIF-1α and VEGF during placentalnes and the expression of markers of apoptosis, hypoxia
ion status (n = 50)
NF IL-4 IL-10
(0.000) 0.398 (0.004) 0.778 (0.000)
(0.000) 0.370 0.659 (0.000)
1 (0.048) −0.343 (0.015) −0.437 (0.002)
(0.000) 0.457 (0.001) 0.763 (0.000)
(0.000) 0.307 (0.030) 0.784 (0.000)
(0.000) 0.249 (0.081) 0.565 (0.000)
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malaria and hypoxia could be confirmed [12].
Cyclooxygenase (COX) and lipoxygenase (LOX) trans-
form fatty acids into prostaglandins and leukotrienes,
which play important roles in pregnancy and foetal de-
velopment. In addition, COX-2 has been proposed as a
marker of preeclampsia and recovery after infectious
conditions [37]. In a study published by Sarr et al.,
increased expression of COX-2 and IL-10 in chronic
placental malaria was detected, and COX-2 was associated
with maternal anaemia, placental macrophage infiltration
and haemozoin deposition [13]. These results are consist-
ent with the findings herein reported regarding increased
COX-2 and IL-10 in cases of placental infection. Further-
more, COX-1 is reported for the first time in association
with placental malaria.
Interestingly, no differences were observed between
the changes in the markers studied in P. vivax infected
placentas compared with those infected with P. falciparum.
Some complications of P. vivax infection might be ex-
plained by the production of pro-inflammatory cyto-
kines, which alter the balance at the foetal-maternal
interface. Based on this, it is hypothesized that P. vivax
is as pathogenic as P. falciparum, regardless of the presence
of sequestering parasites.
The knowledge gathered so far on the pathophysiology of
placental malaria mainly describes cases of P. falciparum
infection. The current results demonstrate that P. vivax
might also be equivalent in the pathophysiology of pla-
cental damage. These results need to be complemented
with a study of a large series of P. vivax infected pla-
centas. In addition, the role of naturally acquired
specific humoral immunity should complement these
studies in order to clarify its implication on clinical
status. Finally, studies of the consequences of P. vivax
placental infection in Asia and America in the context of a
pregnancy vaccine and intermittent preventive therapy
should be a priority.
In conclusion, submicroscopic placental infection by
malaria parasites failed to induce major clinical effects on
mother or foetus but associated with a pro-inflammatory
cytokine profile, regardless of the infecting species, and
this was more evident in the placental tissue. Finally,
increased apoptosis was common in Plasmodium spp.
infected placentas.Competing interests
The authors affirm that they have no commercial or other association that
might pose a conflict of interest.Authors’ contributions
OA, EA BA designed and performed the analysis in blood samples. OA, JC-F
and AM conceived the project and designed the experiments, supervised
overall design and development and wrote the manuscript. SKY designed
the experiments. All authors read and approved the final manuscript.Acknowledgments
The authors are grateful to the participating patients, field assistants,
employees and managers of the local hospitals for their collaboration, Ms.
Sandra Shokoples and Dr. Sédami Gnidehou for assistance in the laboratory.
Financing
This work was supported by the Colciencias (project codes 111549326134
and 111556933361); the Universidad de Antioquia (project code IIM 8764–2557);
Estrategia de Sostenibilidad 2013–2014, and Banco de la Republica (code 3069).
Author details
1Grupo “Salud y Comunidad-César Uribe Piedrahita”, Universidad de Antioquia,
Medellin, Colombia. 2Hospital Pablo Tobón Uribe, Laboratorio de Biología
Molecular, Medellín, Colombia. 3School of Public Health, University of Alberta;
Provincial Laboratory for Public Health, Edmonton, Canada.
Received: 10 October 2013 Accepted: 22 March 2014
Published: 27 March 2014
References
1. Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile FO: Quantifying the
number of pregnancies at risk of malaria in 2007: a demographic study.
PLoS Med 2010, 7:e1000221.
2. Desai M, ter Kuile FO, Nosten F: Epidemiology and burden of malaria in
pregnancy. Lancet Infect Dis 2007, 7:93–104.
3. Rogerson SJ, Hviid L, Duffy PE, Leke RF, Taylor DW: Malaria in pregnancy:
pathogenesis and immunity. Lancet Infect Dis 2007, 7:105–117.
4. Fried M, Duffy PE: Adherence of Plasmodium falciparum to chondroitin
sulfate A in the human placenta. Science 1996, 272:1502–1504.
5. Umbers AJ, Boeuf P, Clapham C, Stanisic DI, Baiwog F, Mueller I, Siba P, King
CL, Beeson JG, Glazier J, Rogerson SJ: Placental malaria-associated
inflammation disturbs the insulin-like growth factor axis of fetal growth
regulation. J Infect Dis 2011, 203:561–569.
6. Muehlenbachs A, Fried M, McGready R: A novel histological grading
scheme for placental malaria applied in areas of high and low malaria
transmission. J Infect Dis 2010, 202:1608–1616.
7. Nosten F, Rogerson SJ, Beeson JG, McGready R, Mutabingwa TK, Brabin B:
Malaria in pregnancy and the endemicity spectrum: what can we learn?
Trends Parasitol 2004, 20:425–432.
8. Uneke CJ: Diagnosis of Plasmodium falciparum malaria in pregnancy in
sub-Saharan Africa: the challenges and public health implications.
Parasitol Res 2008, 102:333–342.
9. Uckan D, Steele A, Cherry, Wang BY, Chamizo W, Koutsonikolis A, Gilbert-Barness
E, Good RA: Trophoblasts express Fas ligand: a proposed mechanism for
immune privilege in placenta and maternal invasion. Mol Hum Reprod
1997, 3:655–662.
10. Conroy A, Serghides L, Finney C, Owino SO, Kumar S, Gowda DC, Liles WC,
Moore JM, Kain KC: C5a Enhances dysregulated inflammatory and
angiogenic responses to malaria in vitro: potential implications for
placental malaria. PLoS One 2009, 4:e4953.
11. Lucchi NW, Peterson DS, Moore JM: Immunologic activation of human
syncytiotrophoblast by Plasmodium falciparum. Malar J 2008, 7:42.
12. Boeuf P, Tan A, Romagosa C, Radford J, Mwapasa V, Molyneux ME, Meshnick
SR, Hunt NH, Rogerson SJ: Placental hypoxia during placental malaria.
J Infect Dis 2008, 197:757–765.
13. Sarr D, Aldebert D, Marrama L, Frealle E, Gaye A, Brahim HO, Niang M,
Dangou JM, Mercereau-Puijalon O, Lehesran J, Jambou R: Chronic infection
during placental malaria is associated with up-regulation of
cycloxygenase-2. Malar J 2010, 9:45.
14. Gamain B, Smith JD, Viebig NK, Gysin J, Scherf A: Pregnancy-associated
malaria: parasite binding, natural immunity and vaccine development.
Int J Parasitol 2007, 37:273–283.
15. Campos IM, Uribe ML, Cuesta C, Franco-Gallego A, Carmona-Fonseca J,
Maestre A: Diagnosis of gestational, congenital, and placental malaria in
Colombia: comparison of the efficacy of microscopy, nested polymerase
chain reaction, and histopathology. Am J Trop Med Hyg 2011, 84:929–935.
16. Arango EM, Samuel R, Agudelo OM, Carmona-Fonseca J, Maestre A,
Yanow SK: Molecular detection of malaria at delivery reveals a high
frequency of submicroscopic infections and associated placental
damage in pregnant women from Northwest Colombia. Am J Trop
Med Hyg 2013, 89:178–183.
Agudelo et al. Malaria Journal 2014, 13:122 Page 9 of 9
http://www.malariajournal.com/content/13/1/12217. McGready R, Tan SO, Ashley EA, Pimanpanarak M, Viladpai-Nguen J, Phaiphun L,
Wüstefeld K, Barends M, Laochan N, Keereecharoen L, Lindegardh N,
Singhasivanon P, White NJ, Nosten F: A randomised controlled trial of
artemether-lumefantrine versus artesunate for uncomplicated Plasmodium
falciparum treatment in pregnancy. PLoS Med 2008, 5:e263.
18. Schantz-Dunn J, Nour NM: Malaria and pregnancy: a global health
perspective. Rev Obstet Gynecol 2009, 2:186–192.
19. Arango E, Maestre A, Carmona J: Efecto de la infección submicroscópica o
policlonal de Plasmodium falciparum sobre la madre y el producto de la
gestación Revisión sistemática. Rev Bras Epidemiol 2010, 13:373–386.
20. Rantala AM, Taylor SM, Trottman PA, Luntamo M, Mbewe B, Maleta K, Kulmala T,
Ashorn P, Meshnick SR: Comparison of real-time PCR and microscopy for
malaria parasite detection in Malawian pregnant women. Malar J 2010, 9:269.
21. Carmona-Fonseca J, Maestre A: Incidencia de la malaria gestacional,
congénita y placentaria en Urabá (Antioquia, Colombia), 2005–2007.
Rev Colomb Obstet Ginecol 2009, 60:15.
22. Carmona-Fonseca J, Arango E, Maestre A: Placental malaria in Colombia:
histopathologic findings in Plasmodium vivax and P. falciparum
infections. Am J Trop Med Hyg 2013, 88:1093–1101.
23. Padilla JC, Uribe G, Araújo RM, Narváez PC, Valencia SH: Epidemiology and
control of malaria in Colombia. Mem Inst Oswaldo Cruz 2011, 106:114–122.
24. Agudelo OM, Arango EM, Maestre A, Carmona-Fonseca J: Prevalence of
gestational, placental and congenital malaria in north-west Colombia.
Malar J 2013, 12:341.
25. Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE: Pyrimethamine
and proguanil resistance-conferring mutations in Plasmodium falciparum
dihydrofolate reductase: polymerase chain reaction methods for
surveillance in Africa. Am J Trop Med Hyg 1995, 52:565–568.
26. Shokoples SE, Ndao M, Kowalewska-Grochowska K, Yanow SK: Multiplexed
real-time PCR assay for discrimination of Plasmodium species with improved
sensitivity for mixed infections. J Clin Microbiol 2009, 47:975–980.
27. Pfaffl MW: A new mathematical model for relative quantification in real-time
RT-PCR. Nucleic Acids Res 2001, 29:e45.
28. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell
death in situ via specific labeling of nuclear DNA fragmentation.
J Cell Biol 1992, 119:493–501.
29. Guller S, Ma YY, Fu HH, Krikun G, Abrahams VM, Mor G: The placental
syncytium and the pathophysiology of preeclampsia and intrauterine
growth restriction: a novel assay to assess syncytial protein expression.
Ann N Y Acad Sci 2008, 1127:129–133.
30. Crocker IP, Tanner OM, Myers JE, Bulmer JN, Walraven G, Baker PN:
Syncytiotrophoblast degradation and the pathophysiology of the
malaria-infected placenta. Placenta 2004, 25:273–282.
31. Aschkenazi S, Straszewski S, Verwer KM, Foellmer H, Rutherford T, Mor G:
Differential regulation and function of the Fas/Fas ligand system in
human trophoblast cells. Biol Reprod 2002, 66:1853–1861.
32. Tkachuk AN, Moormann AM, Poore JA, Rochford RA, Chensue SW, Mwapasa
V, Meshnick SR: Malaria enhances expression of CC chemokine receptor 5
on placental macrophages. J Infect Dis 2001, 183:967–972.
33. Kossodo S, Monso C, Juillard P, Velu T, Goldman M, Grau GE: Interleukin-10
modulates susceptibility in experimental cerebral malaria. Immunology 1997,
91:536–540.
34. Kabyemela ER, Muehlenbachs A, Fried M, Kurtis JD, Mutabingwa TK, Duffy
PE: Maternal peripheral blood level of IL-10 as a marker for inflammatory
placental malaria. Malar J 2008, 7:26.
35. Cooke BM, Mohandas N, Cowman AF, Coppel RL: Cellular adhesive
phenomena in apicomplexan parasites of red blood cells. Vet Parasitol
2005, 132:273–295.
36. Takem EN, D’Alessandro U: Malaria in pregnancy. Mediterr J Hematol Infect
Dis 2013, 5:e2013010.
37. Koga K, Aldo PB, Mor G: Toll-like receptors and pregnancy: trophoblast as
modulators of the immune response. J Obstet Gynaecol Res 2009, 35:191–202.
doi:10.1186/1475-2875-13-122
Cite this article as: Agudelo et al.: Submicroscopic infection of placenta
by Plasmodium produces Th1/Th2 cytokine imbalance, inflammation
and hypoxia in women from north-west Colombia. Malaria Journal
2014 13:122.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
